Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Infinity Pharmaceuticals missed estimated earnings by 7.69%, reporting an EPS of $-0.14 versus an estimate of $-0.13.
Revenue was up $185.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 13.53% increase in the share price the next day.
Here's a look at Infinity Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.13 | -0.14 | -0.12 |
| EPS Actual | -0.13 | -0.12 | -0.13 | -0.15 |
| Revenue Estimate | 300.00K | 520.00K | 280.00K | 1.15M |
| Revenue Actual | 451.00K | 428.00K | 512.00K | 467.00K |
To track all earnings releases for Infinity Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
